Merck agrees acquisition of Grzybowski Scientific Inventions

Merck has announced the acquisition of Grzybowski Scientific Inventions, a developer of software supporting chemical synthesis activities in academic and industrial settings.

Established in December 2013, the company owns exclusive licensing, development, marketing and sales rights to a chemistry decision-making and synthetic planning software product Chematica.

It uses advanced reaction rules and proprietary algorithms to identify synthesis pathways that meet user-defined constraints, with this virtual synthesis approach reducing the time between chemical target conception and route evaluation by filtering data points.

Merck expects this acquisition to complement its existing e-commerce platform and chemistry portfolio of more than 400,000 building blocks, catalysts and reagents for chemical synthesis.

Udit Batra, a member of Merck's executive board and chief executive officer for life science, said: "With a 350-year legacy in the pharmaceutical and chemistry business, we recognise the attractiveness of the chemical synthesis and cheminformatics market and how it complements our existing leadership position in chemicals and reagents."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.